— Know what they know.
Not Investment Advice
Also trades as: ROMJF (OTC) · $vol 0M

ROMJ.V TSXV

Rubicon Organics Inc.
1W: -2.1% 1M: -13.2% 3M: +2.2% YTD: +5.8% 1Y: -22.0% 3Y: -4.2% 5Y: -81.0%
C$0.46 ($0.32)
-0.01 (-1.09%)
 
TSXV · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 35 · C$30.6M mcap · 38M float · 0.174% daily turnover

Income Trends

Revenue
$59M +22.1% ▲
5Y CAGR: +44.7%
Gross Profit
-$7M -144.0% ▼
Operating Income
-$15M -1210.4% ▼
Net Income
$1M +141.0% ▲
EPS (Diluted)
$0.02 +135.3% ▲
EBITDA
-$15M -925.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$23M$36M$40M$49M$59M
YoY Growth+140.9%+57.1%+12.9%+21.4%+22.1%
Cost of Revenue$21M$22M$27M$33M$66M
Gross Profit$2M$14M$13M$15M-$7M
Gross Margin6.7%38.9%32.8%31.7%-11.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$15M$16M$14M$16M$9M
Operating Expenses$15M$16M$14M$17M$9M
Operating Income-$13M-$3M-$1M-$1M-$15M
Operating Margin-58.6%-7.3%-2.7%-2.4%-25.8%
Interest Expense$1M$1M$1M$1M$707K
Income Before Tax-$15M-$4M-$2M-$3M$1M
Tax Expense$0$0$0$0$0
Net Income-$15M-$4M-$2M-$3M$1M
Net Margin-64.2%-10.9%-4.5%-5.3%1.8%
EPS (Diluted)$-0.26$-0.07$-0.03$-0.04$0.02
EBITDA-$11M$217K$2M$2M-$15M
Shares Outstanding55M56M56M59M67M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms